To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: σ-1 receptor

Ophthalmic disease

INDICATION: Blindness

Mouse studies suggest agonizing the σ-1 receptor could help prevent

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE